GEODE CAPITAL MANAGEMENT, LLC - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 61 filers reported holding IMMUNE DESIGN CORP in Q1 2017. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q1 2019$2,467,000
+158.1%
421,833
-42.7%
0.00%
Q4 2018$956,000
-21.3%
735,680
+109.1%
0.00%
Q3 2018$1,214,000
-20.2%
351,915
+5.2%
0.00%
Q2 2018$1,521,000
+60.6%
334,471
+16.5%
0.00%
Q1 2018$947,000
-14.7%
287,031
+0.8%
0.00%
Q4 2017$1,110,000
-13.1%
284,690
+130.5%
0.00%
Q3 2017$1,278,000
+18.4%
123,522
+11.5%
0.00%
Q2 2017$1,079,000
+53.7%
110,734
+7.2%
0.00%
Q1 2017$702,000
+32.0%
103,298
+6.8%
0.00%
Q4 2016$532,000
-22.9%
96,729
+6.2%
0.00%
Q3 2016$690,000
+36.6%
91,096
+47.1%
0.00%
Q2 2016$505,000
-36.6%
61,924
+0.9%
0.00%
Q1 2016$797,000
-33.7%
61,384
+2.5%
0.00%
-100.0%
Q4 2015$1,202,000
+70.5%
59,887
+3.6%
0.00%
Q3 2015$705,000
-38.4%
57,795
+4.2%
0.00%
-100.0%
Q2 2015$1,145,000
+56.8%
55,458
+60.2%
0.00%
Q1 2015$730,000
-31.1%
34,628
+0.5%
0.00%
-100.0%
Q4 2014$1,060,00034,4590.00%
Other shareholders

There were no reported owners of IMMUNE DESIGN CORP in Q1 2017.

NameSharesValueWeighting ↓
View complete list of IMMUNE DESIGN CORP shareholders